Actively Recruiting
Comparison of Cytokines Profile in Aqueous Humor and Tear Before and After UCP Treatment
Led by Zhongshan Ophthalmic Center, Sun Yat-sen University · Updated on 2024-02-06
200
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Glaucoma is the leading cause of irreversible vision loss in people aged 50 years and older worldwide, second only to cataracts. Ultrasound Cyclo Plasty was first proposed as a new minimally invasive technique in the 1980 s. In recent years, many clinical studies at home and abroad have confirmed the effectiveness, safety and repeatability of UCP. The ciliary body is the target organ of UCP, and the range and accuracy of intraoperative destruction of the ciliary body are the key factors affecting the success or failure of the operation. The production of aqueous humor is closely related to the ciliary body. The dynamic balance of its production and discharge can affect IOP, and its content can directly reflect the intraocular environment. Besides,tears are easy to collect and can be used for follow-up. Previous studies have shown that various proteins in aqueous humor or tear can provide a basis for the pathophysiological changes of glaucoma, and can also be a potential biomarker for predicting the success of anti-glaucoma surgery. At present, UCP related research focuses on its effectiveness and safety, mainly reflected in three aspects : postoperative intraocular pressure, number of anti-glaucoma drugs and complications, and lack of relevant indicators that directly reflect postoperative intraocular environment changes. The purpose of this study was to reveal the changes of cytokines in aqueous humor after UCP in patients with primary glaucoma, to analyze the possible causes of these factors, and to speculate the effect of their interaction on the surgical effect, in order to increase the predictability of UCP procedure.
CONDITIONS
Official Title
Comparison of Cytokines Profile in Aqueous Humor and Tear Before and After UCP Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with glaucoma
- No age or gender restrictions
- Intraocular pressure 21 mmHg or higher under maximum tolerated glaucoma medication, or less than 21 mmHg with progressive optic nerve damage
You will not qualify if you...
- Other eye diseases affecting intraocular pressure
- Use of systemic steroid drugs before surgery
- History of other anti-glaucoma surgery within 3 months
- Eye infection within 2 weeks before Ultrasound Cyclo Plasty
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhognshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510060
Actively Recruiting
Research Team
H
HuanYang Shi, M.D
CONTACT
C
Chengguo Zuo, M.D,Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here